A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

NCT07695597 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Hyperlipidemia

Interventions

DRUG: SYH2070
DRUG: Placebo

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.